Both in Pharmaceuticals
Abeona Therapeutics vs Immuneering
Over the past year ABEO returned −9.0% and IMRX returned −42.9%; their daily moves had a correlation of 0.29.
ABEO −9.0% IMRX −42.9%Growth of $1, one year, split-adjusted
| Metric | ABEO | IMRX |
|---|---|---|
| Price | $4.35 | $3.75 |
| Market cap | $248.8M | $242.5M |
| Today | −4.61% | −6.84% |
| 1 month | −13.2% | −7.1% |
| 6 months | −19.9% | −30.3% |
| Year to date | −17.5% | −43.1% |
| 1 year | −12.8% | −40.1% |
| Revenue growth (YoY) | +2745.0% | — |
| Gross margin | 63.3% | — |
| Net margin | −177.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.7× | — |
| Net cash | $131.8M | $145.4M |
| Dividend yield | — | — |
| Volatility (60d) | 54.5% | 50.8% |
| Short % of float | 36.2% | 29.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).